The main objective of the pilot phase of PGLEXPO will be to assess the faisability and to precise methodology of a case-control study designed for testing the impact of environmental and professional exposures on the tumoral risk in SDHx-mutation carriers
The main objective of the pilot phase of PGLEXPO will be to assess the faisability and to precise methodology of a case-control study designed for testing the impact of environmental and professional exposures on the tumoral risk in SDHx-mutation carriers. Patients will be selected from subjects with a mutation in one of the SDHx genes. The cases will have developed a tumor, while the controls will be tumor-free. Controls will be matched to the cases according to sex, age and type of gene affected. Past exposures will be sought through a telephone questionnaire.
Study Type
OBSERVATIONAL
Enrollment
100
Feasability of the protocol of a national case/control study (PGL.EXPO2)
Successful pairing of 50 cases with 50 controls
Time frame: 2 years
Feasibility of matching cases and controls
Proportion of cases for which a control could be identified
Time frame: 2 years
Ease of matching cases and controls
Mean number of controls matching for a case
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.